Search Results 2681-2690 of 17718 for rheumatoid arthritis
Recently, antibodies against the proinflammatory cytokine tumor necrosis factor-alpha appeared to be very effective in treating patients with Crohn's disease.
Visible retinal pathology as assessed by ophthalmic examination that is considered a risk factor for RVO or RPED such as: Evidence of new optic disc cupping ...
Prior chemotherapy or immunotherapy (tumor vaccine, cytokine or growth factor given to control the cancer: systemic or IT) must have been completed at least ...
Patients may have received targeted agents (angiogenesis inhibitors, epidermal growth factor receptor [EGFR] inhibitors, mammalian target of rapamycin [mTOR] ...
Vascular endothelial growth factor, FLT-1, and FLK-1 analysis in a pancreatic cancer tissue microarray. Cancer. 2006 Apr 15; 106(8):1677-84. View PubMed ...
The primary objective of this study is to determine the safety and tolerability of utilizing the insulin-like growth factor-1-methotrexate conjugate, 765IGF ...
This medicine is available without a prescription. This product is available in the following dosage forms: Lotion; Cream. Back to top ...
The human epidermal growth factor receptor 2 (HER2) regulates cell growth and survival. Approximately 15-20% of all breast cancers are HER2-positive, which ...
ritis, Arthritis, Periprosthetic fracture, Sarcoma, Bone metastasis, Avascular necrosis, Infected total hip replacement, Infected total knee replacement ...
chronic non-steroidal anti-inflammatory drug (NSAID) use (note: occasional use of NSAIDs and acetaminophen [e.g., headache, arthritis, myalgias, or ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your Annual Fund gift can drive advancements in cancer care.